Submit Deal

Submit Deal

Cover Image Christopher Viehbacher

Christopher Viehbacher

President and CEO at BIOGEN INC

Manager

Deal Bio

Total Deals3

Valued Deals3

Total Value£ 7.40 B

Avg. Deal Size£ 2.47 B

Market Context

Sort

28 Jul 2023|United States|Pharmaceuticals

Target: REATA PHARMACEUTICALS INC

Bidder: BIOGEN INC

9 Service Providers

4 Target | 5 Bidder

60 Dealmakers

38 Target | 22 Bidder

£ 5.66 B

Value

22 May 2024|United States|Biotechnology

Target: HUMAN IMMUNOLOGY BIOSCIENCES

Bidder: BIOGEN INC

7 Service Providers

5 Target | 2 Bidder

19 Dealmakers

4 Target | 15 Bidder

£ 1.42 B

Value

10 Jan 2025|United States|Pharmaceuticals

Target: SAGE THERAPEUTICS

Bidder: BIOGEN INC

3 Service Providers

2 Target | 1 Bidder

6 Dealmakers

5 Target | 1 Bidder

£ 324 M

Value

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy

Privacy Policy Terms of Service Contact Us Cookie Preferences

All rights reserved. Copyright © 2025 Datasite